Search results for "Ejection fraction"

showing 10 items of 378 documents

Development of a Severity Score System for Thalassemia Syndromes

2019

Introduction Thalassemia Syndromes (TS) are a group of inherited haemoglobin disorders characterized by different phenotype severity falling among heterozygote state, no transfusion dependent thalassemia (NTDT) and transfusion dependent Thalassemia (TDT) (Graffeo et al, 2018; Taher & Saliba, 2017). Several factors, independently by genotype and globin chain unbalance, modulate the severity of ineffective erythropoiesis (Rivella et al, 2015). Considering the complexity of this pathophysiology, one tool to evaluate patients on an individual basis is needed. The aim of this study was to develop a severity scoring system with a view to initiate timely interventions that would prevent any fu…

Ineffective erythropoiesismedicine.medical_specialtyEjection fractionbusiness.industryThalassemiaImmunologyCancerGlobin chainCell BiologyHematologyLogistic regressionmedicine.diseasemedicine.disease_causeBiochemistryInternal medicineSeverity of illnessmedicinebusinessBlood
researchProduct

Do the current guidelines for heart failure diagnosis and treatment fit with clinical complexity?

2022

Heart failure (HF) is a clinical syndrome defined by specific symptoms and signs due to structural and/or functional heart abnormalities, which lead to inadequate cardiac output and/or increased intraventricular filling pressure. Importantly, HF becomes progressively a multisystemic disease. However, in August 2021, the European Society of Cardiology published the new Guidelines for the diagnosis and treatment of acute and chronic HF, according to which the left ventricular ejection fraction (LVEF) continues to represent the pivotal parameter for HF patients’ evaluation, risk stratification and therapeutic management despite its limitations are well known. Indeed, HF has a complex pathophys…

Left ventricular ejection fractiontherapyacute heart failureheart failure left ventricular ejection fraction New York Heart Association classification acute heart failure chronic heart failure phenotypes pathophysiology therapyAcute heart failure; Chronic heart failure; Heart failure; Left ventricular ejection fraction; New York Heart Association classification; Pathophysiology; Phenotypes; TherapyRphenotypesAcute heart failureheart failureHeart failureleft ventricular ejection fractionGeneral MedicineNew York Heart Association classificationPathophysiologyChronic heart failurechronic heart failurePhenotypesMedicineTherapyacute heart failure; chronic heart failure; heart failure; left ventricular ejection fraction; new york heart association classification; pathophysiology; phenotypes; therapypathophysiology
researchProduct

Comparison of different segmentation approaches without using gold standard. Application to the estimation of the left ventricle ejection fraction fr…

2011

International audience; A statistical method is proposed to compare several estimates of a relevant clinical parameter when no gold standard is available. The method is illustrated by considering the left ventricle ejection fraction derived from cardiac magnetic resonance images and computed using seven approaches with different degrees of automation. The proposed method did not use any a priori regarding with the reliability of each method and its degree of automation. The results showed that the most accurate estimates of the ejection fraction were obtained using manual segmentations, followed by the semiautomatic methods, while the methods with the least user input yielded the least accu…

MESH : Ventricular Function Left[ INFO.INFO-TS ] Computer Science [cs]/Signal and Image Processing[INFO.INFO-TS] Computer Science [cs]/Signal and Image Processing[ SPI.SIGNAL ] Engineering Sciences [physics]/Signal and Image processing02 engineering and technologyMESH: Regression AnalysisVentricular Function LeftArticleMESH: Ventricular Function Left030218 nuclear medicine & medical imagingMESH: Magnetic Resonance Imaging03 medical and health sciencesMESH : Heart0302 clinical medicine[INFO.INFO-TS]Computer Science [cs]/Signal and Image ProcessingMESH : Magnetic Resonance ImagingMESH : Regression Analysis0202 electrical engineering electronic engineering information engineeringHumansMedicineSegmentation[ SDV.IB ] Life Sciences [q-bio]/BioengineeringReliability (statistics)[SPI.SIGNAL] Engineering Sciences [physics]/Signal and Image processing[SDV.IB] Life Sciences [q-bio]/BioengineeringEjection fractionMESH: Humansbusiness.industryMESH : HumansHeartRegression analysisPattern recognitionImage segmentationGold standard (test)Magnetic Resonance ImagingMESH: Heartmedicine.anatomical_structureVentricleRegression AnalysisA priori and a posteriori020201 artificial intelligence & image processing[SDV.IB]Life Sciences [q-bio]/BioengineeringArtificial intelligencebusinessNuclear medicine[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing
researchProduct

The role of macrophage colony-stimulating factor in patients with acute myocardial infarction: a pilot study.

2011

We assessed whether macrophage colony-stimulating factor (M-CSF) levels are associated with left ventricular systolic dysfunction (LVSD) in patients with acute myocardial infarction (AMI). We studied 56 patients with AMI (mean age: 67 ± 12 years) and identified those with clinical (Killip class >II) or echocardiographic signs (ejection fraction ≤45%) of LVSD. We evaluated the established cardiovascular risk factors and measured several cardiovascular biomarkers, including M-CSF. Serum M-CSF concentrations (pg/mL) were significantly increased in patients with both clinical and echocardiographic signs of LVSD (460 ± 265 vs 290 ± 210, P = .0103 and 493 ± 299 vs 287 ± 174, P = .0028, respec…

Macrophage colony-stimulating factorMalemedicine.medical_specialtymacrophage colony-stimulating factor myocardial infarction heart failureMyocardial InfarctionPilot ProjectsLogistic regressionVentricular Dysfunction LeftPredictive Value of TestsInternal medicineMedicineHumansMyocardial infarctionKillip classAgedEjection fractionbusiness.industryMacrophage Colony-Stimulating FactorOdds ratiomedicine.diseaseConfidence intervalPredictive value of testsCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersAngiology
researchProduct

Circulating monocyte subsets and heart failure prognosis

2018

Altres ajuts: Fundacio' La MARATO' de TV3 (201502 to ABG, 201516), AdvanceCat with the support of ACCIÓ [Catalonia Trade & Investment, Generalitat de Catalunya], Fundació Bancària La Caixa. Monocytes are a heterogeneous population of effector cells with key roles in tissue integrity restoration and maintenance. Here, we explore the association of monocyte subsets and prognosis in patients with ambulatory heart failure (HF). Monocyte subsets were classified as classical (CD14 ++ /CD16 -), intermediate (CD14 ++ /CD16 +), or non-classical (CD14 + /CD16 ++). Percentage distribution and absolute cell count were assessed in each subset, and multivariable Cox regression analyses were performed wit…

Male0301 basic medicineEtiologylcsh:Medicine030204 cardiovascular system & hematologyPathology and Laboratory MedicineMonocytesWhite Blood CellsMathematical and Statistical Techniques0302 clinical medicineAnimal CellsCell MovementRisk FactorsCause of DeathMedicine and Health Scienceslcsh:ScienceCause of deathMultidisciplinaryEjection fractionHeartPrognosismedicine.anatomical_structurePhysical SciencesAmbulatoryCardiologyRegression AnalysisFemaleCellular TypesAnatomyStatistics (Mathematics)Research Articlemedicine.medical_specialtyImmune CellsCD14ImmunologyCell Enumeration TechniquesCardiologyResearch and Analysis MethodsDisease-Free Survival03 medical and health sciencesDiagnostic MedicineInternal medicinemedicineHumansStatistical MethodsAgedProportional Hazards ModelsHeart FailureBlood Cellsbusiness.industryProportional hazards modelMonocytelcsh:RBiology and Life SciencesCell Biologymedicine.disease030104 developmental biologyVentricleHeart failureCardiovascular Anatomylcsh:QbusinessMathematicsEjection FractionPLOS ONE
researchProduct

Short-term moderate diet restriction in adulthood can reverse oxidative, cardiovascular and metabolic alterations induced by postnatal overfeeding in…

2016

AbstractWe aimed to determine whether moderate diet restriction could restore cardiac, oxidative and metabolic alterations induced by postnatal overfeeding (PNOF). Litters of C57BL/6 male mice were either maintained at 9 (normal litter, NL), or reduced to 3 (small litter, SL) in order to induce PNOF. At 6 months, half of the NL and SL mice were subjected to 20% calorie-restriction (CR: NLCR, SLCR) for one month, while the other half continued to eat ad libitum (AL: NLAL, SLAL). Six-month old SL mice presented overweight, fat accumulation, hyperleptinemia, glucose intolerance, insulin resistance, increased cardiac ROS production and decreased left ventricular ejection fraction (LVEF). After …

Male0301 basic medicineLitter Size[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionAdipose tissueMitochondria HeartMice0302 clinical medicine[SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMultidisciplinaryEjection fractionHigh-Fat Diet[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemAdipose-Tissuecoronary-heart-disease;adipose-tissue;insulin-resistance;blood-pressure;weight-gain;rats;obesity;high-fat diet;caloric restriction;glucocorticoid metabolismAlimentation et NutritionBlood-PressureBody Compositionmedicine.symptommedicine.medical_specialtyRespiratory rate030209 endocrinology & metabolismOxidative phosphorylationCarbohydrate metabolismBiologyArticle03 medical and health sciencesInsulin resistanceMetabolic Diseases[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicinemedicineFood and NutritionAnimalsObesityGlucocorticoid MetabolismCaloric RestrictionWeight-GainInsulin-ResistanceBody Weightmedicine.diseaseRatsMice Inbred C57BL[SDV.AEN] Life Sciences [q-bio]/Food and NutritionOxidative Stress030104 developmental biologyEndocrinologyBlood pressureAnimals NewbornInsulin ResistanceCoronary-Heart-Disease[SDV.AEN]Life Sciences [q-bio]/Food and NutritionWeight gainScientific Reports
researchProduct

Immunity, Inflammation and Heart Failure. Their Role on Cardiac Function and Iron Status

2019

Aims: Heart failure is a clinical syndrome characterized by subclinical systemic inflammation and immune system activation associated with iron deficiency. No data exist on the various activations of immune-mediated mechanisms of inflammation in heart failure patients with reduced/preserved ejection fraction. We aimed to (1) investigate possible differences in inflammatory parameters and oxidative stress, and (2) detect a different iron status between groups. Materials and Methods: We enrolled 50 consecutive Caucasian outpatients with heart failure. All patients underwent echocardiographic measurements, laboratory determinations, evaluation of iron status and Toll-like receptors, and NF-κB …

Male0301 basic medicineheart failureSystemic inflammationGastroenterologyVentricular Function LeftElectrocardiographychemistry.chemical_compound0302 clinical medicineiron deficiencyImmunology and Allergyejection fraction; heart failure; inflammation; iron deficiency; toll-like receptorejection fractionOriginal ResearchAged 80 and overEjection fractionbiologymedicine.diagnostic_testToll-Like ReceptorsIron deficiencyMiddle AgedHeart Function TestsSerum ironCytokinesFemaleDisease SusceptibilityInflammation Mediatorsmedicine.symptomlcsh:Immunologic diseases. AllergyCardiac function curvemedicine.medical_specialtyIronImmunology03 medical and health sciencesHepcidinsInternal medicinemedicineHumansAgedCreatininebusiness.industryImmunitymedicine.diseaseFerritinOxidative Stress030104 developmental biologychemistryinflammationHeart failurebiology.proteintoll-like receptorlcsh:RC581-607businessBiomarkers030215 immunology
researchProduct

Incidence, determinants and prognostic relevance of dyspnea at admission in patients with Takotsubo syndrome: results from the international multicen…

2020

AbstractClinical presentation of Takotsubo syndrome (TTS) may range from acute chest pain to dyspnea: the prognostic role of clinical onset is still controversial. Aim of this study was therefore to investigate the prognostic relevance of dyspnea at presentation in patients with TTS. We analyzed 1,071 TTS patients (median age 72 years, 90% female) enrolled in the international multicenter GEIST registry. Patients were divided according to the presence or absence of dyspnea at hospital admission, as clinically assessed by the accepting physician. The primary endpoint was occurrence of in-hospital complications defined as a composite of pulmonary edema, cardiogenic shock and death. Overall, 3…

Male0301 basic medicinemedicine.medical_specialtyShock CardiogenicCardiologylcsh:MedicinePulmonary EdemaArticleacute coronary syndrome03 medical and health sciences0302 clinical medicineRisk FactorsTakotsubo CardiomyopathyInternal medicinemedicineClinical endpointtakotsubo syndromeHumansRegistriesSigns and symptomslcsh:ScienceTakotsubo syndrome (TTS) chest pain.AgedMultidisciplinaryEjection fractionbusiness.industryIncidenceIncidence (epidemiology)Cardiogenic shockHazard ratiolcsh:RAtrial fibrillationtakotsubo syndrome; dyspnea; acute coronary syndromeOdds ratioMiddle AgedPrognosismedicine.diseasePulmonary edemaHospitalizationDyspnea030104 developmental biologyFemalelcsh:Qbusiness030217 neurology & neurosurgeryScientific Reports
researchProduct

Invasive Strategy in Patients With Advanced Diabetes and Non-ST-Segment Elevation Acute Coronary Syndrome. Angiographic Findings and Clinical Follow-…

2006

Introduction and objectives Advanced diabetes can be associated with diffuse coronary artery disease that is difficult to treat by revascularization. We studied angiographic findings and disease progression in patients with advanced diabetes (either insulin-dependent or taking antidiabetic drugs for >5 years) and non-ST-elevation acute coronary syndrome who were being treated using an invasive strategy. Methods The study included 141 patients. The extent of the coronary artery disease was quantified using a score derived from a 29-segment coronary angiogram. The composite endpoint was death, myocardial infarction, or readmission for unstable angina within one year of follow-up. Results The …

MaleAcute coronary syndromemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionCoronary AngiographyRevascularizationDiabetes ComplicationsCoronary artery diseaseElectrocardiographyInternal medicineDiabetes mellitusMyocardial RevascularizationmedicineHumansAngina UnstableProspective StudiesMyocardial infarctionAgedKillip classEjection fractionUnstable anginabusiness.industrySyndromeGeneral Medicinemedicine.diseaseAcute DiseaseDisease ProgressionCardiologyFemalebusinessFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL Study

2018

AbstractPatients with heart failure (HF) are frequently anti-coagulated with vitamin K-antagonists (VKAs). The use of long-acting VKA may be preferable for HF patients due to higher stability of plasma concentrations. However, evidence on phenprocoumon-based oral anti-coagulation (OAC) therapy in HF is scarce. The aim of this study was to assess the impact of the presence of HF on quality of phenprocoumon-based OAC and the subsequent clinical outcome. Quality of OAC therapy and the incidence of adverse events were analysed in a cohort of regular care (n = 2,011) from the multi-centre thrombEVAL study program (NCT01809015) stratified by the presence of HF. To assess the modifiability of outc…

MaleAdministration Oralheart failureclinical outcomeED AMERICAN-COLLEGE030204 cardiovascular system & hematologyTHERAPY ANTITHROMBOTIC THERAPYCohort StudiesPhenprocoumon0302 clinical medicinequality of careGermanyProspective Studies030212 general & internal medicineProspective cohort studyAged 80 and overOUTCOMESIncidenceHazard ratioHematologyTreatment OutcomeCohortFemaleCLINICAL-PRACTICE GUIDELINESSINUS RHYTHMmedicine.drugCohort studyRiskmedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsHemorrhageWARFARINEJECTION FRACTION03 medical and health sciencesInternal medicinemedicineHumansAdverse effectAgedbusiness.industryWarfarinhealth care modelAnticoagulantsmedicine.diseaseoral anti-coagulationHeart failureATRIAL-FIBRILLATIONPhenprocoumonADVERSE EVENTSbusinessANTICOAGULANT-THERAPY
researchProduct